Nutrition Education Program for Cancer Patients Receiving Radiotherapy
The Effect of Nutrition Education Program on the Nutrition Status and Life Quality of Cancer Patients Receiving Radiotherapy
1 other identifier
interventional
200
1 country
1
Brief Summary
Using randomized control study, explore the effect of novel nutrition education program on the nutrition status and life quality of cancer patients receiving radiotherapy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2022
CompletedFirst Posted
Study publicly available on registry
April 15, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedNovember 15, 2022
April 1, 2022
2.1 years
April 7, 2022
November 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
risk of malnutrition
Nutrition Risk Screening 2002 is used to assess the risk of malnutrition.
Week 0, 12
BMI
Body mass index is a measure of body fat based on height and weight that applies to adult men and women. It equals to weight divided by height square.
Week 0, 12
albumin
level of serum albumin
Week 0, 12
Quality of Life (QOL)
The QOL was measured by the European Organization for Research and Treatment quality of life version 3 questionnaire (EORTC QLQ-C30) simplified Chinese version. It contains five functional scales (physical, role, cognitive, emotional, and social), three symptoms scales (fatigue, pain, and nausea and vomiting), a global health scale, a number of single items assessing additional symptoms commonly reported by cancer patients (dyspnea, appetite loss, insomnia, constipation, and diarrhea) and financial impact of the disease. For most items, four response categories from 1 (not at all) to 4 (very much) are employed; two items (overall health, overall quality of life) have response categories ranging from 1 to 7. A high scale score represents a higher response level. Thus a high score for a functional scale, the global health status or overall QOL represents a high or healthy status or a high QOL; however, a high score for the symptom scales represents a high level of symptom.
Week 0, 12
Secondary Outcomes (2)
physical function status
Week 0, 12
Knowledge-Attitude-Practice
Week 0, 12
Study Arms (2)
Arm A
EXPERIMENTALNovel nutrition program : Give nutrition health education every week and regular survey and intervention. The education booklets are made based on the guideline and characteristics of the disease.
Arm B
ACTIVE COMPARATORRoutine nutrition education Give nutrition education if the patient visits the clinics. Irregular survey and intervention were given to the patients.
Interventions
Give nutrition health education every two weeks and regular survey and intervention. The education booklets are made based on the guideline and characteristics of the disease.
Eligibility Criteria
You may qualify if:
- Patients are diagnosed with cancer and receive radiotherapy, especially in head and neck cancer, lung cancer, or esophageal cancer.
- Patients need nutrition support treatment
- Informed consent
You may not qualify if:
- Critical patients or life expectancy \< 12 weeks
- Patients with severe hepatic cirrhosis, Chronic Obstructive Pulmonary Disease, chronic renal failure, intestinal obstruction, stroke.
- Unconscious or psychiatric patients
- Patients with communication problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taipei Medical University WanFang Hospitallead
- Asia Universitycollaborator
Study Sites (1)
Szu-Yuan Wu
Taipei, Please Select, 116, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Szu-Yuan Wu
Asia University, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- single blind (Participant)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2022
First Posted
April 15, 2022
Study Start
December 1, 2022
Primary Completion
December 30, 2024
Study Completion
December 30, 2025
Last Updated
November 15, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- data will become available on June 30 2022.
- Access Criteria
- requirement with official application
study completed